860 related articles for article (PubMed ID: 35443531)
21. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
Abeysekera KWM; Orr JG; Gordon FH; Howe LD; Hamilton-Shield J; Heron J; Hickman M
BMC Gastroenterol; 2022 Jun; 22(1):323. PubMed ID: 35773644
[TBL] [Abstract][Full Text] [Related]
22. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus.
Yang LJ; Zhou JZ; Zheng YF; Hu X; He ZY; Du LJ; Gu X; Huang XY; Li J; Li YQ; Pan LY; Zhang XX; Gu XJ
J Endocrinol Invest; 2023 Aug; 46(8):1565-1572. PubMed ID: 36725809
[TBL] [Abstract][Full Text] [Related]
23. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease.
Navarroza AMC; Wong SN
Indian J Gastroenterol; 2021 Aug; 40(4):380-388. PubMed ID: 34213749
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.
Sinha N; Mukhopadhyay S; Sau M
Indian J Gastroenterol; 2020 Feb; 39(1):75-83. PubMed ID: 32314167
[TBL] [Abstract][Full Text] [Related]
25. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
[TBL] [Abstract][Full Text] [Related]
26. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study.
Kempiński R; Łukawska A; Krzyżanowski F; Ślósarz D; Poniewierka E
Adv Clin Exp Med; 2019 Dec; 28(12):1615-1620. PubMed ID: 31025557
[TBL] [Abstract][Full Text] [Related]
28. Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank.
Chahal D; Sharma D; Keshavarzi S; Arisar FAQ; Patel K; Xu W; Bhat M
Hepatol Int; 2022 Apr; 16(2):325-336. PubMed ID: 35178663
[TBL] [Abstract][Full Text] [Related]
29. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
30. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
[TBL] [Abstract][Full Text] [Related]
31. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
[TBL] [Abstract][Full Text] [Related]
32. Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients.
Denkmayr L; Feldman A; Stechemesser L; Eder SK; Zandanell S; Schranz M; Strasser M; Huber-Schönauer U; Buch S; Hampe J; Paulweber B; Lackner C; Haufe H; Sotlar K; Datz C; Aigner E
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30562976
[TBL] [Abstract][Full Text] [Related]
33. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
Tang A; Ng CH; Phang PH; Chan KE; Chin YH; Fu CE; Zeng RW; Xiao J; Tan DJH; Quek J; Lim WH; Mak LY; Wang JW; Chew NWS; Syn N; Huang DQ; Siddiqui MS; Sanyal A; Muthiah M; Noureddin M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1750-1760.e12. PubMed ID: 35863685
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
[TBL] [Abstract][Full Text] [Related]
37. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
[TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic fatty liver disease (NAFLD) in lean individuals - Single centre large cohort clinicopathologic and immunophenotypic study.
Rastogi A; Rath I; Varadarajan A; Ramakrishna G; Bihari C; Maiwall R
Pathol Res Pract; 2022 Oct; 238():154112. PubMed ID: 36126451
[TBL] [Abstract][Full Text] [Related]
39. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
[TBL] [Abstract][Full Text] [Related]
40. Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD.
De A; Mehta M; Singh P; Bhagat N; Mitra S; Das A; Duseja A
Int J Obes (Lond); 2023 Oct; 47(10):986-992. PubMed ID: 37474570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
